HomeIKT • NASDAQ
add
Inhibikase Therapeutics Inc
Previous close
$1.86
Day range
$1.67 - $1.82
Year range
$0.79 - $4.35
Market cap
11.08M USD
Avg Volume
55.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.00 | -100.00% |
Operating expense | 1.40M | 4.18% |
Net income | -4.18M | 2.36% |
Net profit margin | -417.79M | -6,206,294.55% |
Earnings per share | — | — |
EBITDA | -4.40M | -1.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.25M | -42.51% |
Total assets | 14.51M | -41.83% |
Total liabilities | 3.53M | -9.54% |
Total equity | 10.98M | — |
Shares outstanding | 6.48M | — |
Price to book | 1.05 | — |
Return on assets | -67.98% | — |
Return on capital | -81.89% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.18M | 2.36% |
Cash from operations | -3.44M | 3.20% |
Cash from investing | -2.12M | -142.63% |
Cash from financing | -138.10K | — |
Net change in cash | -5.70M | -504.95% |
Free cash flow | -2.55M | -27.85% |
About
Founded
2008
Headquarters
Website
Employees
8